EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 updateArticle Published on 2022-12-012023-07-08 Journal: Annals of the rheumatic diseases [Category] COVID19(2023년), [키워드] antirheumatic agents COVID-19 vaccination. [DOI] 10.1136/annrheumdis-2021-222006 PMC 바로가기
Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registryObservational Study Published on 2022-12-012023-07-10 Journal: Clinical Rheumatology [Category] COVID19(2023년), [키워드] antirheumatic agents Coronavirus disease 2019 Observational Rheumatic diseases Risk factors. [DOI] 10.1007/s10067-022-06305-w PMC 바로가기 [Article Type] Observational Study
SARS-CoV-2 Omicron escapes mRNA vaccine booster-induced antibody neutralisation in patients with autoimmune rheumatic diseases: an observational cohort studyObservational Study Published on 2022-11-012023-07-10 Journal: Annals of the rheumatic diseases [Category] COVID19(2023년), [키워드] antirheumatic agents Autoimmune diseases COVID-19 vaccination. [DOI] 10.1136/ard-2022-222689 PMC 바로가기 [Article Type] Observational Study
Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory diseaseArticle Published on 2022-07-012023-07-07 Journal: Annals of the rheumatic diseases [Category] COVID19(2023년), [키워드] antirheumatic agents biological therapy. COVID-19 [DOI] 10.1136/annrheumdis-2021-221554 PMC 바로가기
Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohortArticle Published on 2022-06-012023-07-08 Journal: Annals of the rheumatic diseases [Category] COVID19(2023년), [키워드] antirheumatic agents Arthritis COVID-19 vaccination. [DOI] 10.1136/annrheumdis-2021-221922 PMC 바로가기
The effect of COVID-19 pandemic in a large series of patients with Takayasu arteritisArticle Published on 2022-06-012023-07-10 Journal: Turkish Journal of Medical Sciences [Category] COVID19(2023년), [키워드] antirheumatic agents COVID-19 Takayasu arteritis vaccination. [DOI] 10.55730/1300-0144.5347 PMC 바로가기
Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019Article Published on 2022-05-122023-06-16 Journal: The Korean journal of internal medicine [Category] MERS, [키워드] antirheumatic agents COVID-19 Hydroxychloroquine Immunosuppressive agents SARS-CoV-2 [DOI] 10.3904/kjim.2020.633 PMC 바로가기
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)면역매개염증질환(RESCUE)에서 DMARD 치료를 일시적으로 중단한 후 COVID-19 ChAdOx1nCov-19 및 BNT162b 백신에 대한 항체 반응Randomized Controlled Trial Published on 2022-05-012022-09-11 Journal: RMD Open [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, 치료제, [키워드] Adult patients Antibody Response Antibody responses antirheumatic agents AstraZeneca AZ vaccine baseline biologic BNT162b Control control group control groups controls COVID-19 csDMARD dose Final first and second dose first dose first vaccination group groups IgG Immune-mediated immunogenicity inflammatory disease Messenger RNA multicentre not significantly different Patient Pfizer Protein randomised randomised controlled trial registration number response S1/S2 SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV2 second dose second vaccination Seroconversion seroconversion rate seroconversion rates significantly lower the antibody response the mean therapy titre titres U/mL vaccination vaccination. Vaccine were measured [DOI] 10.1136/rmdopen-2022-002301 PMC 바로가기 [Article Type] Randomized Controlled Trial
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort studyArticle Published on 2022-04-012023-07-08 Journal: RMD Open [Category] COVID19(2023년), [키워드] antirheumatic agents Autoimmune diseases biological therapy COVID-19 epidemiology. [DOI] 10.1136/rmdopen-2021-002035 PMC 바로가기
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registryArticle Published on 2022-04-012023-07-08 Journal: RMD Open [Category] COVID19(2023년), [키워드] antirheumatic agents COVID-19 vaccination. [DOI] 10.1136/rmdopen-2021-002187 PMC 바로가기